Literature DB >> 12611581

Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients.

Patrick Pessaux1, Simon Msika, David Atalla, Jean-Marie Hay, Yves Flamant.   

Abstract

HYPOTHESIS: Infectious complications are the main causes of postoperative morbidity in abdominal surgery. Identification of risk factors, which could be avoided in the perioperative period, may reduce the rate of postoperative infectious complications.
DESIGN: A database was established from 3 prospective, randomized, multicenter studies. Multivariate analysis was performed using nonconditional logistic regression expressed as an odds ratio (OR).
SETTING: Multicenter studies (ie, private medical centers, institutional hospitals, and university hospitals). PATIENTS: From June 1982 to September 1996, a database was established containing the information of 4718 patients who underwent noncolorectal abdominal surgery. MAIN OUTCOME MEASURES: The dependent variables studied included surgical site infection (SSI) (divided into parietal and deep infectious complications with or without fistulas) and global infectious complications (SSI and extraparietal and abdominal infectious complications).
RESULTS: The rate of global infectious complications was 13.3%; SSI, 4.05%; parietal infectious complications, 2.2%; deep infectious complications with fistulas, 2.18%; and deep infectious complications without fistulas, 1.38%. In multivariate analysis, the following 7 independent risk factors for global infectious complications have been identified: age (60-74 years, OR, 1.64; >or=75 years, OR, 1.45); being underweight (OR, 1.51); having cirrhosis (OR, 2.45), having a vertical abdominal incision (OR, 1.66); having a suture placed or an anastomis of the bowel (OR, 1.48) in the digestive tract; having a prolonged operative time (61-120 minutes, OR, 1.66; 121 minutes, OR, 2.72); and being categorized as having a class 4 surgical site (ie, obese patients or having a risk factor of a healing defect) (OR, 1.66). Ceftriaxone sodium therapy was identified as a protective factor (OR, 0.43). In multivariate analysis, the following 5 independent risk factors for SSI have been identified: the existence of a preoperative cutaneous abscess or cutaneous necrosis (OR, 4.75), having a suture placed or an anastomosis of the bowel (OR, 1.82) in the digestive tract, having postoperative abdominal drainage (OR, 2.15), undergoing a surgical procedure for the treatment of cancer (OR, 1.74), and receiving curative anticoagulant therapy (OR, 3.33) postoperatively.
CONCLUSIONS: Our data show that risk factors for SSI and for global infectious complications are disparate. Indeed, only the placement of a suture or having an anastomosis of the bowel in the digestive tract is a risk factor for both SSI and global infections. Some of these factors may be modifiable before or during the surgical procedure to reduce the infection rate or to prevent postoperative complications.

Entities:  

Mesh:

Year:  2003        PMID: 12611581     DOI: 10.1001/archsurg.138.3.314

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  53 in total

1.  Peritonitis from an abdominal wall biloma: a unique reason to avoid prophylactic surgical drainage.

Authors:  S G Thrumurthy; V D Shetty; J B Ward; K G Pursnani; M M Mughal
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

2.  Retromuscular mesh repair of midline incisional hernia with polyester standard mesh: monocentric experience of 261 consecutive patients with a 5-year follow-up.

Authors:  Tigran Poghosyan; Nicolas Veyrie; Nicola Corigliano; Nada Helmy; Stephane Servajean; Jean-Luc Bouillot
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

3.  Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients.

Authors:  Manabu Kawai; Masaji Tani; Hiroshi Terasawa; Shinomi Ina; Seiko Hirono; Ryohei Nishioka; Motoki Miyazawa; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 4.  A multi-disciplinary review of the potential association between closed-suction drains and surgical site infection.

Authors:  Alyssa J Reiffel; Philip S Barie; Jason A Spector
Journal:  Surg Infect (Larchmt)       Date:  2013-05-29       Impact factor: 2.150

5.  Risk factors for incisional surgical site infections in elective surgery for colorectal cancer: focus on intraoperative meticulous wound management.

Authors:  Keita Itatsu; Gen Sugawara; Yuji Kaneoka; Takehito Kato; Eiji Takeuchi; Michio Kanai; Hiroshi Hasegawa; Toshiyuki Arai; Yukihiro Yokoyama; Masato Nagino
Journal:  Surg Today       Date:  2013-08-06       Impact factor: 2.549

Review 6.  Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery.

Authors:  Manabu Kawai; Hiroki Yamaue
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

7.  Survey of surgical antimicrobial prophylaxis in czech republic.

Authors:  Retnosari Andrajati; Jiri Vlcek; Milan Kolar; Ráchel Pípalová
Journal:  Pharm World Sci       Date:  2005-12

8.  Does internal stenting of the pancreaticojejunostomy improve outcomes after pancreatoduodenectomy? A prospective study.

Authors:  Vassilios Smyrniotis; Nikolaos Arkadopoulos; Maria A Kyriazi; Michael Derpapas; Theodosios Theodosopoulos; Constantinos Gennatas; Agathi Kondi-Paphiti; Ioannis Vassiliou
Journal:  Langenbecks Arch Surg       Date:  2010-03       Impact factor: 3.445

9.  Risk factor of surgical site infection after pancreaticoduodenectomy.

Authors:  Teiichi Sugiura; Katsuhiko Uesaka; Norio Ohmagari; Hideyuki Kanemoto; Takashi Mizuno
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

10.  Obesity should not influence the management of appendicitis.

Authors:  S Towfigh; F Chen; N Katkhouda; R Kelso; H Sohn; T V Berne; R J Mason
Journal:  Surg Endosc       Date:  2008-03-18       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.